[
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 3,
    "category": "Agreement Date"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 4,
    "category": "Effective Date"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 5,
    "category": "Expiration Date"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 7,
    "category": "Notice Period To Terminate Renewal"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 18,
    "category": "Anti-Assignment"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 25,
    "category": "License Grant"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 26,
    "category": "Non-Transferable License"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 32,
    "category": "Post-Termination Services"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 37,
    "category": "Warranty Duration"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REOUEST. REDACTED MATERIAL IS",
    "bbox": [
      127,
      84,
      1000,
      94
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "THIS AGREEMENT (this \"Agreement'), dated December 30, 2016 (the \"Effective Date\"), is",
    "bbox": [
      111,
      129,
      793,
      142
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "BETWEEN:",
    "bbox": [
      112,
      162,
      199,
      172
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Paratek Pharmaceuticals, Inc., a company having a place of business at 75 Park Plaza, 4th Floor, Boston, MA 02116, USA (\"Customer')",
    "bbox": [
      112,
      194,
      1000,
      206
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "AND:",
    "bbox": [
      111,
      225,
      156,
      237
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CARBOGEN AMCIS AG, a company having a place of business at Hauptstrasse 171, CH 4416 Bubendorf, Switzerland (\"Supplier\"' and, collectively",
    "bbox": [
      111,
      257,
      1000,
      270
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "with Customer, the \"Parties', and each, a \"Party).",
    "bbox": [
      110,
      273,
      478,
      286
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "WHEREAS:",
    "bbox": [
      112,
      306,
      202,
      317
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A. Customer is the owner of certain technology and patent rights regarding the Product (as defined herein) having the description set out in Exhibit.",
    "bbox": [
      112,
      337,
      1000,
      350
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "A (Description of Product) and Exhibit B (Chemical Synthesis);",
    "bbox": [
      111,
      353,
      583,
      367
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "B. Customer has filed / intends to file for approval with the United States Food and Drug Administration and/or its foreign equivalents, an",
    "bbox": [
      111,
      386,
      1000,
      398
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Investigational New Drug Application (\"IND\") and a New Drug Application (\"NDA\"), and/or the foreign equivalents thereof, for certain",
    "bbox": [
      112,
      402,
      1000,
      414
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "formulations containing the Product;.",
    "bbox": [
      111,
      417,
      389,
      430
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "C. Supplier is engaged in the business of performing contracted process development, Manufacturing and supply services of active pharmaceutical.",
    "bbox": [
      112,
      450,
      1000,
      462
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "ingredients (\"APIs\") and intermediates; and.",
    "bbox": [
      110,
      465,
      444,
      478
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "D. Customer desires that Supplier Manufacture the Product in bulk quantities, and Supplier desires to perform such services, each on the terms and.",
    "bbox": [
      110,
      497,
      1000,
      510
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "conditions set out in this Agreement..",
    "bbox": [
      111,
      514,
      391,
      526
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "NOw THEREFORE, in consideration of the premises and the mutual covenants and agreements contained herein and other good and valuable",
    "bbox": [
      110,
      545,
      1000,
      558
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:",
    "bbox": [
      113,
      562,
      958,
      573
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Article 1 Interpretation.",
    "bbox": [
      112,
      601,
      290,
      613
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "1.1 Definitions",
    "bbox": [
      112,
      625,
      226,
      636
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "In this Agreement, in addition to words and phrases defined where they are used, the following words and phrases shall have the following",
    "bbox": [
      110,
      648,
      1000,
      663
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "meanings:",
    "bbox": [
      111,
      666,
      189,
      679
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "a) \"Affiliate\"' of a Party shall mean any entity, directly or indirectly, controlling, controlled by, or under common control with a Party. For purposes.",
    "bbox": [
      112,
      698,
      1000,
      710
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "CONFIDENTIAL",
    "bbox": [
      111,
      743,
      239,
      754
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Page 7 of 49",
    "bbox": [
      1000,
      742,
      1000,
      757
    ],
    "label": 38,
    "category": "Insurance"
  },
  {
    "text": "Source: PARATEK PHARMACEUTICALS, INC., 10-K/A, 5/5/2017",
    "bbox": [
      133,
      1000,
      631,
      1000
    ],
    "label": 38,
    "category": "Insurance"
  }
]